Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GeoVax Labs, Inc. Director's Dealing 2012

Jan 4, 2012

35063_dirs_2012-01-04_0df34435-0c2c-42e4-b89b-e31df6377011.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GeoVax Labs, Inc. (GOVX)
CIK: 0000832489
Period of Report: 2011-12-30

Reporting Person: ROBINSON HARRIET L (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-30 Common Stock P 149254 $0.67 Acquired 1201226 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-30 Stock Purchase Warrant $1 P 223881 Acquired 2016-12-30 Common Stock (223881) Direct